SCHEMBL31479974

SCHEMBL31479974

CCC(CNCc1ccccc1)(c1ccccc1)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
TDP1 Q9NUW8 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
HTT P42858 2/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
XBP1 P17861 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 1/20 0.38
THRB P10828 1/20 0.38
MAOA P21397 1/20 0.38
TMEM97 Q5BJF2 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
RIPK1 Q13546 1/20 0.37
KCNN4 O15554 1/20 0.37
CHRM2 P08172 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31479981 0.78 MEN1 (0.51) MEN1KMT2ATDP1SMN1; SMN2LMNA
SCHEMBL30139610 0.73 TAAR1 (0.48) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL5802025 0.72 KCNN4 (0.45) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL11162858 0.72 MEN1 (0.50) MEN1KMT2ATDP1SMN1; SMN2TP53
SCHEMBL10688173 0.72 KCNN4 (0.45) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL23474625 0.72 MEN1 (0.50) MEN1KMT2ATDP1TP53THRB
SCHEMBL19858983 0.72 KCNN4 (0.45) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL28859359 0.72 KCNN4 (0.45) MEN1KMT2ASMN1; SMN2LMNAALDH1A1
SCHEMBL29264736 0.71 CYP1A2 (0.48) SMN1; SMN2LMNAALDH1A1MAOASIGMAR1
SCHEMBL15114173 0.70 MEN1 (0.49) MEN1KMT2ATDP1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051434-A1 MONOVALENT INTERLEUKIN 12 (IL-12) HETERODIMERIC FC PROTEINS MERCK SHARP & DOHME LLC (US) 2025-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051434-A1 MONOVALENT INTERLEUKIN 12 (IL-12) HETERODIMERIC FC PROTEINS IL2RA, IL2, FCGR2A MEN1 1701/4885KMT2A 2295/4885TDP1 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.